Search the Newsreel

Is Kenvue Stock Attractive After Margin Gains and Deal Uncertainty

Kenvue Inc (KVUE) Financial Health: Profitability & Balance Sheet Analysis

Kenvue Inc (KVUE) has a stable financial score of 7.35, ranking 18th in the Personal & Household Products & Services industry. The company reported a 4.49% year-over-year increase in revenue to $3.91 billion and a significant 47.20% rise in net profit for its latest …

Kenvue Inc. stock rises Monday, outperforms market

Kenvue Inc. (KVUE) shares increased by 1.04% to $19.48 on Monday, outperforming the broader market. Both the S&P 500 Index and the Dow Jones Industrial Average also saw gains. This marks the second consecutive day of increases for Kenvue's stock.

First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE

First Trust Advisors LP significantly reduced its stake in Kenvue Inc. by 13.6% in the first quarter, now holding 2,888,992 shares valued at $49.81 million. Despite this reduction, institutional investors collectively own 97.64% of Kenvue's stock. The article also details recent insider stock sales, …

Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC

Gabelli Funds LLC significantly increased its stake in Kenvue Inc. by 71.2% in Q1, acquiring 301,350 additional shares, bringing their total holding to 724,635 shares valued at $12.5 million. Kenvue (KVUE) reported strong quarterly earnings of $0.32 EPS, beating estimates, and a 4.5% year-over-year …

Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE

Absolute Gestao de Investimentos Ltda. has acquired a new position in Kenvue Inc. (NYSE:KVUE), purchasing 923,260 shares valued at approximately $15.92 million, making it their 16th largest holding. Other institutional investors have also adjusted their stakes, with some increasing their holdings significantly. Kenvue's stock …

Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE)

Kenvue recently received FDA approval for Tylenol with Naproxen, a new over-the-counter pain reliever offering up to 12 hours of pain relief and slated for distribution across major U.S. retailers. This product launch adds a differentiated option to Kenvue's Self Care portfolio, potentially strengthening …

Is Kenvue (KVUE) Stock A Bargain With Lawsuits Back In Focus?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Kenvue stock has delivered a decline of 11.7% over the past year, yet the current Discounted Cash Flow (DCF) intrinsic value estimate indicates …

Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The FDA's approval of Tylenol with Naproxen, a new over the counter pain reliever offering up to 12 hours of relief, has put Kenvue …

5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC

Kryger Capital LLC has acquired a significant new stake in Kenvue Inc. (NYSE:KVUE), purchasing over 5.2 million shares valued at approximately $89.84 million, making it their sixth-largest holding. Other institutional investors like Healthcare of Ontario Pension Plan Trust Fund and Renaissance Technologies LLC also …

GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE

GABELLI & Co INVESTMENT ADVISERS INC. increased its stake in Kenvue Inc. (NYSE:KVUE) by 77.3% in the first quarter, now owning 742,600 shares valued at $12.8 million. Other institutional investors also modified their holdings, while Kenvue recently declared a quarterly dividend of $0.2075 per …

Kenvue, Inc. Revenue Breakdown – FWB:J4D

Kenvue, Inc. (FWB:J4D) generated €12.88 billion in revenue last year, with its Self Care segment being the top performer, contributing €5.43 billion. The United States was the company's largest regional contributor, accounting for €5.50 billion in the same period. The report provides a financial …

FDA Clears Kenvue's TYLENOL With Naproxen, First OTC Fixed-Dose Combination

(RTTNews) - Kenvue Inc. (KVUE) announced that the FDA has approved TYLENOL with Naproxen, the first and only over the counter fixed dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) for pain relief. This new formulation combines the fast-acting relief of …

Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Kenvue Inc (KVUE) by business segment and geographical region. As of April 6, the company generated $2.87 billion from Face and Body Care and $2.42 billion from Other Self Care, with Northern America contributing the highest …

Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a detailed historical overview of Kenvue Inc (KVUE) dividends and stock splits, including past and upcoming payout dates and amounts. It lists the dividend record dates, payment dates, and ex-dividend dates, detailing both interim and final cash dividends. The document also …

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

An Illinois Appellate Court upheld a US$45 million verdict against Johnson & Johnson for asbestos-contaminated talc, also confirming Kenvue's successor liability. This ruling reinforces the ongoing legal exposure Kenvue faces due to legacy talc products, even as it pursues a merger with Kimberly Clark. …

US FDA approves over-the-counter Tylenol combination pill for pain relief

The U.S. Food and Drug Administration has approved an over-the-counter combination pill of Kenvue's Tylenol and naproxen for up to 12 hours of pain relief. This approval aligns with "The Great Healthcare Plan" to increase the availability of safe pharmaceutical drugs for OTC purchase. …

Kenvue Inc (KVUE) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Kenvue Inc (KVUE), listing its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding data over several quarters historically, and recent shareholder activity by key institutions. The report also lists ETFs that …

Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE

Mizuho Markets Americas LLC significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 85.0% in the first quarter, selling over 12 million shares and now holding 2.1 million shares. Despite this, other institutional investors have either increased or initiated positions in Kenvue. The company …

Capula Management Ltd Grows Position in Kenvue Inc. $KVUE

Capula Management Ltd significantly increased its holdings in Kenvue Inc. (NYSE: KVUE) by 137.7% in the first quarter, now owning 2.25 million shares. This comes as Kenvue reported strong Q1 earnings, beating analyst estimates with an EPS of $0.32 and revenue of $3.91 billion, …

Kenvue Inc. stock falls Thursday, still outperforms market

Kenvue Inc. (KVUE) stock fell 1.20% on Thursday, closing at $18.90, despite a broader market downturn where the S&P 500 and Dow Jones Industrial Average also experienced declines. The company's stock still outperformed the overall market indices. Kenvue Inc. is currently 17.36% below its …

Kenvue to announce Q2 2026 results on August 6, 2026

Kenvue Inc. will release its Q2 2026 financial results before market open on August 6, 2026. The company will not hold a conference call due to a pending transaction with Kimberly-Clark, and the results will be available on its investor relations website. This announcement …

Kenvue Will Release Q2 Results Aug. 6 Without Conference Call

Kenvue Inc. (NYSE: KVUE) announced it will release its second quarter 2026 financial results on August 6, 2026, before the market opens. The company will not host a quarterly conference call due to a pending transaction with Kimberly-Clark. Results will be available on Kenvue's …

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

SUMMIT, N.J., July 23, 2026--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) will announce its second quarter 2026 financial results before the market opens on August 6, 2026. Due to the pending transaction with Kimberly-Clark, Kenvue will not be hosting a quarterly conference call to review its …

Technical Reactions to KVUE Trends in Macro Strategies

This article provides a technical analysis of Kenvue Inc. (NASDAQ: KVUE), highlighting a strong near-term sentiment while mid and long-term outlooks are neutral. It identifies a significant risk-reward short setup and offers three institutional trading strategies tailored for different risk profiles and holding periods, …

Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts

Kenvue Inc. (NYSE:KVUE) has received an average "Hold" rating from sixteen analysts, with thirteen recommending a hold and three a buy. The average 1-year price target for the stock is $19.5833. Recent analyst commentary includes ratings cuts and increases, with the company reporting strong …

Kenvue broadens China focus on minor ailment management

Kenvue, a US-based consumer health company, is expanding its focus on minor ailment management in China due to rising health awareness and demand for self-care products. The company plans to broaden its product portfolio, enhance public health education, and collaborate with pharmacies and online …

SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE

SEB Asset Management AB has acquired a new position in Kenvue Inc. (NYSE:KVUE) during the first quarter, purchasing 437,872 shares valued at approximately $7.55 million. Kenvue reported strong Q1 results, exceeding EPS and revenue expectations, and declared a quarterly dividend of $0.2075 per share, …

Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE

Dimensional Fund Advisors LP significantly increased its stake in Kenvue Inc., now owning 22.27 million shares valued at $383.94 million. This comes after Kenvue beat earnings expectations with $3.91 billion in revenue and an EPS of $0.32, and the company offers an annualized dividend …

What to Expect From Kenvue’s Q2 2026 Earnings Report

Kenvue Inc. (KVUE), the world's largest pure-play consumer health company, is preparing to report its fiscal 2026 second-quarter results, with analysts expecting a 10.3% year-over-year increase in earnings per share to $0.32. Despite consistently beating earnings estimates, the stock has underperformed the broader market …

Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda

Kapitalo Investimentos Ltda significantly reduced its stake in Kenvue Inc. (NYSE:KVUE) by 97.2% in the first quarter, selling 1,944,000 shares. Despite this sell-off, Kenvue reported stronger-than-expected quarterly results with EPS of $0.32 and revenue of $3.91 billion, a 4.5% year-over-year increase. The company offers …

Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE

The Swiss National Bank increased its stake in Kenvue Inc. by 6.9% during the first quarter, now owning 5,622,946 shares worth $96.94 million. Several other institutional investors also adjusted their positions in Kenvue, with significant increases from Independent Franchise Partners LLP, Sculptor Capital LP, …

Kenvue stock trades steadily as consumer health spin-off builds earnings record

Kenvue, the consumer health spin-off from Johnson & Johnson, has established its earnings record since its 2023 separation, reporting over $15 billion in revenue and initiating a regular dividend. The company's financials show stable operating margins and strong cash flow, with a focus on …

After Hours Most Active for Jul 20, 2026 : NVDA, CMCSA, INTC, HDB, KVUE, AAPL, WMT, PLTR, DVN, VZ, ESI, UPS

The NASDAQ 100 After Hours Indicator is down -13.85 to 28,590.38. The total After hours volume is currently 108,486,190 shares traded. The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is -0.78 at $202.50, with 4,403,392 shares traded. …

Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC

HSBC Holdings PLC increased its stake in Kenvue Inc. (NYSE:KVUE) by 10% in the first quarter, reaching 5.62 million shares worth approximately $96.6 million. Kenvue's recent earnings report beat expectations with an EPS of $0.32 and revenue of $3.91 billion, marking a 4.5% year-over-year …

Listerine Cool Mint by Kenvue Inc. - mouthwash classic fuels recurring sales

Listerine Cool Mint, a classic mouthwash by Kenvue Inc., is a significant driver of recurring sales and a core product in the company's oral care portfolio. Its enduring popularity stems from its unique sensory profile, clinical backing for reducing plaque and gingivitis, and strong …